Roles of Hormone Replacement Therapy and Menopause on Osteoarthritis and Cardiovascular Disease Outcomes: A Narrative Review

Osteoarthritis (OA) is a highly prevalent condition characterized by degradation of the joints. OA and cardiovascular disease (CVD) are leading contributors to disease burden worldwide, with a high level of overlap between the risk factors and occurrence of both conditions. Chief among the risk fact...

Full description

Bibliographic Details
Main Authors: Yixue Mei, Jennifer S. Williams, Erin K. Webb, Alison K. Shea, Maureen J. MacDonald, Baraa K. Al-Khazraji
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Rehabilitation Sciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fresc.2022.825147/full
_version_ 1797967391379947520
author Yixue Mei
Jennifer S. Williams
Erin K. Webb
Alison K. Shea
Maureen J. MacDonald
Baraa K. Al-Khazraji
author_facet Yixue Mei
Jennifer S. Williams
Erin K. Webb
Alison K. Shea
Maureen J. MacDonald
Baraa K. Al-Khazraji
author_sort Yixue Mei
collection DOAJ
description Osteoarthritis (OA) is a highly prevalent condition characterized by degradation of the joints. OA and cardiovascular disease (CVD) are leading contributors to disease burden worldwide, with a high level of overlap between the risk factors and occurrence of both conditions. Chief among the risk factors that contribute to OA and CVD are sex and age, which are both independent and interacting traits. Specifically, the prevalence of both conditions is higher in older women, which may be mediated by the occurrence of menopause. Menopause represents a significant transition in a women's life, and the rapid decline in circulating sex hormones, estrogen and progesterone, leads to complex physiological changes. Declines in hormone levels may partially explain the increase in prevalence of OA and CVD in post-menopausal women. In theory, the use of hormone therapy (HT) may buffer adverse effects of menopause; however, it is unclear whether HT offers protective effects for the onset or progression of these diseases. Studies have shown mixed results when describing the influence of HT on disease risk among post-menopausal women, which warrants further exploration. The roles that increasing age, female sex, HT, and CVD play in OA risk demonstrate that OA is a multifaceted condition. This review provides a timely consolidation of current literature and suggests aims for future research directions to bridge gaps in the understanding of how OA, CVD, and HT interact in post-menopausal women.
first_indexed 2024-04-11T02:30:29Z
format Article
id doaj.art-a6177a3ea46d4391be93deef97560167
institution Directory Open Access Journal
issn 2673-6861
language English
last_indexed 2024-04-11T02:30:29Z
publishDate 2022-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Rehabilitation Sciences
spelling doaj.art-a6177a3ea46d4391be93deef975601672023-01-02T21:40:21ZengFrontiers Media S.A.Frontiers in Rehabilitation Sciences2673-68612022-03-01310.3389/fresc.2022.825147825147Roles of Hormone Replacement Therapy and Menopause on Osteoarthritis and Cardiovascular Disease Outcomes: A Narrative ReviewYixue Mei0Jennifer S. Williams1Erin K. Webb2Alison K. Shea3Maureen J. MacDonald4Baraa K. Al-Khazraji5Department of Kinesiology, Faculty of Science, McMaster University, Hamilton, ON, CanadaDepartment of Kinesiology, Faculty of Science, McMaster University, Hamilton, ON, CanadaDepartment of Kinesiology, Faculty of Science, McMaster University, Hamilton, ON, CanadaDepartment of Obstetrics and Gynaecology, Faculty of Medicine, McMaster University, Hamilton, ON, CanadaDepartment of Kinesiology, Faculty of Science, McMaster University, Hamilton, ON, CanadaDepartment of Kinesiology, Faculty of Science, McMaster University, Hamilton, ON, CanadaOsteoarthritis (OA) is a highly prevalent condition characterized by degradation of the joints. OA and cardiovascular disease (CVD) are leading contributors to disease burden worldwide, with a high level of overlap between the risk factors and occurrence of both conditions. Chief among the risk factors that contribute to OA and CVD are sex and age, which are both independent and interacting traits. Specifically, the prevalence of both conditions is higher in older women, which may be mediated by the occurrence of menopause. Menopause represents a significant transition in a women's life, and the rapid decline in circulating sex hormones, estrogen and progesterone, leads to complex physiological changes. Declines in hormone levels may partially explain the increase in prevalence of OA and CVD in post-menopausal women. In theory, the use of hormone therapy (HT) may buffer adverse effects of menopause; however, it is unclear whether HT offers protective effects for the onset or progression of these diseases. Studies have shown mixed results when describing the influence of HT on disease risk among post-menopausal women, which warrants further exploration. The roles that increasing age, female sex, HT, and CVD play in OA risk demonstrate that OA is a multifaceted condition. This review provides a timely consolidation of current literature and suggests aims for future research directions to bridge gaps in the understanding of how OA, CVD, and HT interact in post-menopausal women.https://www.frontiersin.org/articles/10.3389/fresc.2022.825147/fullmenopauseosteoarthritiscardiovascular diseasehormone therapyaging/ageingcardiovascular disease risk factors
spellingShingle Yixue Mei
Jennifer S. Williams
Erin K. Webb
Alison K. Shea
Maureen J. MacDonald
Baraa K. Al-Khazraji
Roles of Hormone Replacement Therapy and Menopause on Osteoarthritis and Cardiovascular Disease Outcomes: A Narrative Review
Frontiers in Rehabilitation Sciences
menopause
osteoarthritis
cardiovascular disease
hormone therapy
aging/ageing
cardiovascular disease risk factors
title Roles of Hormone Replacement Therapy and Menopause on Osteoarthritis and Cardiovascular Disease Outcomes: A Narrative Review
title_full Roles of Hormone Replacement Therapy and Menopause on Osteoarthritis and Cardiovascular Disease Outcomes: A Narrative Review
title_fullStr Roles of Hormone Replacement Therapy and Menopause on Osteoarthritis and Cardiovascular Disease Outcomes: A Narrative Review
title_full_unstemmed Roles of Hormone Replacement Therapy and Menopause on Osteoarthritis and Cardiovascular Disease Outcomes: A Narrative Review
title_short Roles of Hormone Replacement Therapy and Menopause on Osteoarthritis and Cardiovascular Disease Outcomes: A Narrative Review
title_sort roles of hormone replacement therapy and menopause on osteoarthritis and cardiovascular disease outcomes a narrative review
topic menopause
osteoarthritis
cardiovascular disease
hormone therapy
aging/ageing
cardiovascular disease risk factors
url https://www.frontiersin.org/articles/10.3389/fresc.2022.825147/full
work_keys_str_mv AT yixuemei rolesofhormonereplacementtherapyandmenopauseonosteoarthritisandcardiovasculardiseaseoutcomesanarrativereview
AT jenniferswilliams rolesofhormonereplacementtherapyandmenopauseonosteoarthritisandcardiovasculardiseaseoutcomesanarrativereview
AT erinkwebb rolesofhormonereplacementtherapyandmenopauseonosteoarthritisandcardiovasculardiseaseoutcomesanarrativereview
AT alisonkshea rolesofhormonereplacementtherapyandmenopauseonosteoarthritisandcardiovasculardiseaseoutcomesanarrativereview
AT maureenjmacdonald rolesofhormonereplacementtherapyandmenopauseonosteoarthritisandcardiovasculardiseaseoutcomesanarrativereview
AT baraakalkhazraji rolesofhormonereplacementtherapyandmenopauseonosteoarthritisandcardiovasculardiseaseoutcomesanarrativereview